tiprankstipranks
Trending News
More News >
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
US Market

BridgeBio Oncology Therapeutics (BBOT) Cash flow

Compare
42 Followers

BridgeBio Oncology Therapeutics Cash Flow

BBOT's free cash flow for Q4 2025 was $-55.55K. For the 2025 fiscal year, BBOT's free cash flow was decreased by $-113.74M and operating cash flow was $-375.55K. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -113.89M$ -763.82K$ 0.00$ 0.00$ 0.00
Investing Cash Flow
$ 73.33M$ -184.00M$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ 383.40M$ 186.46M$ 0.00$ 0.00$ 0.00
End Cash Position
$ 373.82M$ 1.70M$ 0.00$ 0.00$ 0.00
Free Cash Flow
$ -114.50M$ -763.82K$ 0.00$ 0.00$ 0.00
Currency in USD

BridgeBio Oncology Therapeutics Cash Flow